BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Active Motif Acquires Genpathway, Inc. Further Expanding Epigenetics Product Offering


12/2/2010 12:56:04 PM

November 12, 2010 – Active Motif, a leading provider of kits and reagents for the study of epigenetic phenomena, today announced the acquisition of privately-owned Genpathway Inc, of San Diego, CA. Founded in 2001, Genpathway specializes in providing complete service solutions for the genome-wide analysis of epigenetic events, including DNA methylation, histone modification and transcriptional regulation.

“Genome-wide analysis using high-density microarrays or NextGen sequencing has significantly broadened the ability of scientists to understand epigenetic events. However, antibody selection, sample preparation and data analysis can create significant barriers to widespread scientific exploration, especially within biomedical research,” says Joe Fernandez, CEO of Active Motif. “Genpathway’s significant technical know-how, database of characterized antibodies and bioinformatic capabilities remove all of these obstacles.” He continues, “Our goal at Active Motif is to make cutting-edge research accessible to the wider life science community. And, the combination of Genpathway’s expertise in genome-wide analysis and Active Motif’s extensive offerings in ‘off the shelf’ epigenetic-specific tools means that we can now provide life scientists, of all capabilities, with the most comprehensive portfolio of characterized epigenetic products available today”.

“This is a natural extension to the nearly 10 years of expertise that Active Motif has developed in the area of epigenetics. And, in the future we aim to integrate many of Active Motif’s unique research tools within drug discovery and biomarker-related service offerings,” mentions Theodore DeFrank, Active Motif, President.

About Active Motif

Active Motif, Inc. is dedicated to developing, manufacturing and delivering epigenetics-based research tools to analyze nuclear function. Its customers include life scientists from academic and government institutions; biotechnology and pharmaceutical companies; hospitals and reference laboratories. Active Motif operates globally through its corporate headquarters in Carlsbad, California and European headquarters in Rixensart, Belgium, and a worldwide network of sales and support offices. Active Motif applies a multi-disciplinary approach to create new and modify existing technologies to meet the current and future needs of life science researchers.


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->